Randomized n-of-1 Trials: Quality Improvement, Research, or Both?

被引：6
|
作者：
Samuel, Joyce P. [1 ]
Burgart, Alyssa [2 ]
Wootton, Susan H. [1 ]
Magnus, David [2 ]
Lantos, John D. [3 ]
Tyson, Jon E. [1 ]
机构：
[1] Univ Texas Hlth Sci Ctr Houston, McGovern Med Sch, Houston, TX 77030 USA
[2] Stanford Univ, Ctr Bioeth, Palo Alto, CA 94304 USA
[3] Childrens Mercy Hosp, Bioeth Ctr, Kansas City, MO 64108 USA
来源：
PEDIATRICS | 2016年 / 138卷 / 02期
基金：
美国国家卫生研究院;
关键词：
PATIENT SAFETY; ETHICS;
D O I：
10.1542/peds.2016-1103
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
The regulatory demarcations between clinical research and quality improvement (QI) are ambiguous and controversial. Some projects that were undertaken as a form of QI were deemed by regulatory agencies to be research and thus to require institutional review board approval. In the era of personalized medicine, some physicians may ask some patients to participate in n-of-1 trials in an effort to personalize and optimize each patient's medical treatment. Should such activities be considered research, QI, or just excellent personalized medicine? Experts in research, research regulation, and bioethics analyze these issues.
引用
收藏
页数：5
相关论文
共 50 条
  • [31] Demonstrating drug safety: Clinical usefulness of N-of-1 randomized controlled trials
    Knowles, SR
    Neilson, H
    Weber, EA
    Shear, NH
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2002, 109 (01) : S154 - S154
  • [32] N-of-1 Randomized Trials to Assess the Efficacy of Gabapentin for Chronic Neuropathic Pain
    Yelland, Michael J.
    Poulos, Christopher J.
    Pillans, Peter I.
    Bashford, Guy M.
    Nikles, Catherine Jane
    Sturtevant, Joanna M.
    Vine, Norma
    Del Mar, Christopher B.
    Schluter, Philip J.
    Tan, Meng
    Chan, Jonathan
    Mackenzie, Fraser
    Brown, Robyn
    PAIN MEDICINE, 2009, 10 (04) : 754 - 761
  • [33] n-of-1 randomized controlled trials:: An opportunity for complementary and alternative medicine evaluation
    Johnston, BC
    Mills, E
    JOURNAL OF ALTERNATIVE AND COMPLEMENTARY MEDICINE, 2004, 10 (06) : 979 - 984
  • [34] Cluster Randomized Trials for Health Care Quality Improvement Research
    Garrison, Michelle M.
    Mangione-Smith, Rita
    ACADEMIC PEDIATRICS, 2013, 13 (06) : S31 - S37
  • [35] Comparison of Aggregated N-of-1 Trials with Parallel and Crossover Randomized Controlled Trials Using Simulation Studies
    Blackston, J. Walker
    Chapple, Andrew G.
    McGree, James M.
    McDonald, Suzanne
    Nikles, Jane
    HEALTHCARE, 2019, 7 (04) : 1 - 13
  • [36] The possibilities of the use of N-of-1 and do-it-yourself trials in nutritional research
    Krone, Tanja
    Boessen, Ruud
    Bijlsma, Sabina
    van Stokkum, Robin
    Clabbers, S.
    Pasman, Wilrike J.
    PLOS ONE, 2020, 15 (05):
  • [37] Finding Benefit in n-of-1 Trials Reply
    Kravitz, Richard L.
    Schmid, Christopher H.
    Sim, Ida
    JAMA INTERNAL MEDICINE, 2019, 179 (03) : 455 - 455
  • [38] A methodological review of randomised n-of-1 trials
    Hawksworth, Olivia
    Chatters, Robin
    Julious, Steven
    Cook, Andrew
    Biggs, Katie
    Solaiman, Kiera
    Quah, Michael C. H.
    Cheong, Sxe Chang
    TRIALS, 2024, 25 (01)
  • [39] Understanding Variation in Sets of N-of-1 Trials
    Araujo, Artur
    Julious, Steven
    Senn, Stephen
    PLOS ONE, 2016, 11 (12):
  • [40] N-of-1 Trials in Hypertension Are Feasible, but Are They Worthwhile?
    Kravitz, Richard L.
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2019, 34 (06) : 781 - 782
12345